Small Animal Imaging Market To Be Driven By Increasing The Number Of Pharmaceutical & Research Organizations Till 2022:Grand View Research,inc.

Global Small Animal Imaging (In-Vivo) market is expected to reach USD 2.7 billion by 2022, according to a new study by Grand View Research, Inc. Growing number of medical conditions requiring accurate research for development of treatment options is expected to enhance demand for small animal imaging (in-Vivo) over the forecast period. Importance of these devices in applications such as epigenetic research studies, drug receptor targeting, and defining mechanism of action is estimated to provide potential growth platform for this industry. 

The major factors driving the growth of small animal imaging (in-vivo) market are growing usage of multi-functional pre-clinical imaging, rising investments of CROs in pre-clinical studies, increasing number of pharmaceutical and research organizations and technical innovations such as high-resolution MRI with other modalities.

Browse full research report on Small Animal Imaging Market: http://www.grandviewresearch.com/industry-analysis/small-animal-imaging-in-vivo-market

Further key findings from the study suggest:

  • Optical imaging dominated the technology segment in 2014 in terms of revenue share of over 45%. Advantages associated with this technology such as easy and rapid operations and relatively lower costs compared to other devices are the factors attributing for its high share.
  • Micro-MRI technology is expected to be the fastest growing, and is expected to grow at a lucrative CAGR of over 12.0% by 2022. Micro-MRI has wide applications during functional and anatomical analysis in developing mouse neonates and embryos.
  • In term of applications, monitoring treatment response, bio-distribution, cancer cell detection, biomarkers, longitudinal studies and epigenetic studies are segments studied. In 2014, Bio-distribution and monitoring the treatment response dominated the overall market in terms of revenue share of over 33% and 25% respectively.
  • The cancer cell detection segment is expected to show prominent growth rate owing to the rising global prevalence of cancer, and increasing government initiatives pertaining to cancer diagnostics research. Cancer cell detection application is expected to generate revenue of over USD 700 million by 2022, at a CAGR of over 12% from 2015 to 2022.
  • North America dominated in terms of revenue in 2014 at 36.1% in 2014. Favorable platform for R&D pertaining to technological advancements, vast pre-clinical research, established healthcare infrastructure, and rising demand for rapid and advanced methods are the key factors attributing for the highest revenue generation in this region. European market held the second position owing to the large number of pharmaceutical and clinical research organizations and diagnostic device manufacturers.
  • Asia Pacific regional market is expected to register significant growth over the forecast period with CAGR of over 11% owing to emerging economies, growing base of target population, and growing clinical research activities. Additionally, rising acceptance level for advanced medical devices is expected to provide potential growth platform for key players of this market.
  • The key players in this industry include Thermo Fisher Scientific, Inc. Siemens AG, Mediso Medical Imaging Systems, Life Technologies Corporation, Promega Corporation, Miltenyi Biotech GmbH, Bruker Corporation, FujiFilm Holding Corporation, PerkinElmer Inc. and Aspect Imaging Ltd. Companies are developing novel products to sustain their market positions. For instance, Bruker Corporation has launched SKYSCAN 1176, In-vivo micro-CT, and Wrist MRI Machine from Aspect for effortless imaging.
Browse more reports of this category by Grand View Research: http://www.grandviewresearch.com/industry/medical-devices  

Grand View Research has segmented the global small animal imaging (In-Vivo) market on the basis of medium and region:

 Global Small Animal Imaging (In-Vivo) Technology Outlook (Revenue, USD Million, 2012 - 2022)
  • Micro-magnetic resonance imaging
  • Optical imaging
  • Nuclear imaging
  • Other imaging modalities
Global Small Animal Imaging (In-Vivo) Application Outlook (Revenue, USD Million, 2012 - 2022)
  • Monitoring treatment responseCancer cell detection
    • Bio-distribution
  •  
  • Biomarkers
  • Longitudinal studies
  • Epigenetics
Small Animal Imaging (In-Vivo) Regional Outlook (Revenue, USD Million, 2012 - 2022)
  • North America
  • Europe
  • Asia Pacific
  • RoW
About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.


For more information: http://www.grandviewresearch.com

Comments

Popular posts from this blog

The global vein illuminator market is expected to reach USD 358.5 million by 2024, according to a new report published by Grand View Research, Inc. The vein illuminator market is anticipated to witness a lucrative growth during the period 2016 to 2024. The factors contributing towards the growth of the market are the growing aging population and the efforts channelized towards improving patient satisfaction. Additionally, factors, such as the demand for technologically advanced medical equipment and the rising research and practical applications are expected to be opportunistic for the industry growth. However, the prevalence of traditional methods owing to the high costs of the vein illuminator devices is likely to hinder the growth of the market in the near future. The vein illuminator market is segmented on the basis of technology, application, end-user, and region. Based on technology, the market is further categorized into transillumination, infrared technology, and ultrasound. The near-infrared illumination technology is estimated to be the largest shareholder due to its ability to penetrate deep into the tissue, which makes it possible to visualize the vessels clearly. On the basis of application, the market is segmented into intravenous access and blood draw. The end-user segment comprises hospitals, rehabilitation facilities, blood donation camps, and academic institutions. The market for hospitals is expected to grow rapidly during the forecast period due to a surge in the demand for technologically advanced medical equipment. The market is also categorized into North America, Europe, Asia Pacific, MEA, and Latin America. Browse full research report on global Vein Illuminator Market: http://www.grandviewresearch.com/industry-analysis/vein-illuminator-market Further key findings from the study suggest: • In terms of market share, the North America vein illuminator market is expected to hold majority of the share in 2016. Factors resulting in the growth of this industry are the steady preference for highly-advanced medical devices by hospitals as well as the presence of several medical device manufacturing companies in the region. • The infrared illumination technology is estimated to lead the industry due to its deep penetration capability into thick tissues tohighlight the presence of vessels with increased clarity. Based on application, the segment for intravenous access is estimated to be the largest shareholder, followed by the blood draw segment. • The vein illuminator industry comprises several local as well as global players. Some prominent players in this industry include Accuvein, Inc., Christie Medical Holdings, Inc., Infrared Imaging Systems, Inc., Translite, LLC, and Venoscope, LLC,among others. In order to hold a major share in the industry, the companies are adopting both organic as well as inorganic strategies. The major strategies adopted by the companies are new product development, mergers, collaborations, partnerships, geographical expansions, and acquisitions. • The companies are also focusing on research and development activities in order to enhance their product portfolio. For instance, in September 2015, Accuvein, Inc., declared its 26th patent, which was issued by the United States Patent and Trademark office for their vein visualization system. Browse more reports of this category by Grand View Research: http://www.grandviewresearch.com/industry/medical-devices Grand View Research has segmented the vein illuminator market on the basis of technology, application, and end-user application: Vein Illuminator Technology Outlook (Revenue, USD Million, 2013 - 2024) • Transillumination • Infrared technology • Others Vein Illuminator Application Outlook (Revenue, USD Million, 2013 - 2024) • Intravenous access • Blood draw • Others Vein Illuminator End-user Outlook (Revenue, USD Million, 2013 - 2024) • Hospitals • Blood donation camps • Academic institutions • Others Vein Illuminator Regional Outlook (Revenue, USD Million, 2013 - 2024) • North America • Europe • Asia Pacific • Latin America • MEA Access press release of this research report by Grand View Research: http://www.grandviewresearch.com/press-release/global-vein-illuminator-market About Grand View Research Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare. Contact: Sherry James Corporate Sales Specialist, USA Grand View Research, Inc For more information: www.grandviewresearch.com

Hyaluronic Acid Market Is Likely To Be Influenced By The Increase In Obesity Till 2024: Grand View Research, Inc.

Protein Purification & Isolation Market Is Predicted To Grow Swiftly Due To Increased Research In The Fields Of Biotechnology & Pharmaceuticals Till 2025: Grand View Research, Inc.